Comparison of the Effects of a Cardioselective and a Nonselective β-Blocker on Portal Hypertension in Patients with Cirrhosis
✍ Scribed by Patrick Hillon; Didier Lebrec; Cristina Muńoz; Michel Jungers; Gerard Goldfarb; Jean-Pierre Benhamou
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 348 KB
- Volume
- 2
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Republic of China Wedged hepatic venous pressure, free hepatic venous pressure and cardiac index were measured before and 1 hr after i.v. administration as well as 1 month and 3 months after chronic oral administration of verapamil in 10 patients with HBsAg-positive cirrhosis. The gradient bet
Having complications of portal hypertension is a harbinger of decompensated cirrhosis and warrants consideration for liver transplantation (LT). Racial disparities in LT have been reported. We sought to characterize disparities in the performing of surgical and endoscopic procedures among hospitaliz
Little is known about the effects of the pathological process associated with idiopathic portal hypertension (IPH) on hepatic lymph vessels or lymph flow. We used morphometric analysis to examine IPH-associated changes in lymph vessels and branches of the portal vein, with use of immunohistochemical
Reduced intrahepatic endothelial nitric oxide synthase (eNOS) activity contributes to the pathogenesis of portal hypertension (PHT) associated with cirrhosis. We evaluated whether asymmetric dimethylarginine (ADMA), a putative endogenous NOS inhibitor, may be involved in PHT associated with cirrhosi
A nocturnal increase in portal pressure and blood flow was demonstrated in patients with cirrhosis, suggesting Patients. Fourteen patients with cirrhosis (10 men and 4 women, that these hemodynamic changes may contribute to the mean age 53 { 6 years [mean { SEM]; range, 35-63 years) were triggering